other Cancer Research Results
other, other: Click to Expand ⟱
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
chemoP↑, other↝,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
BT549 |
|
|
|
- |
in-vivo, |
BC, |
MDA-MB-231 |
|
|
|
ROS↑, DNAdam↑, selectivity↑, TumCG↓, RadioS↑, Dose↝, selectivity↑, other↝, eff↓, eff↑, γH2AX↑, Dose↓, eff↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
Vim↑, TumCI↓, TumCMig↓, TumMeta↓, Vim↓, other↝,
| - |
Review, |
BC, |
SkBr3 |
|
|
|
- |
Review, |
neuroblastoma, |
SK-N-SH |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
PDH↑, TumCG↓, ROS↑, AMPK↑, EGR4↓, Half-Life↓, BioAv↝, *GSH↑, *IronCh↑, *ROS↓, *antiOx↑, *neuroP↑, *Ach↑, *lipid-P↓, *IL1β↓, *IL6↓, TumCP↓, FDG↓, Apoptosis↑, AMPK↑, mTOR↓, EGFR↓, TumCI↓, TumCMig↓, *memory↑, *BioAv↑, *BioAv↝, *other↓, *other↝, *Half-Life↓, *BioAv↑, *ChAT↑, *GlucoseCon↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
other↝, TumCP↓,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Liver, |
Hep3B |
|
|
|
- |
in-vitro, |
AML, |
K562 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
TumCP↓, eff↑, other↝,
other↓, other↝, Hcy/homoC↓, eff↝, other↝,
*other↝, *BioAv↓, eff↑, toxicity↓, eff↑, TumCD↑, Half-Life↑, selectivity↑, EPR↑, ROS↑, Apoptosis↑, eff↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
selectivity↑, other↝, Apoptosis↑, DR4↑, Casp9↑, Casp8↑, Bax:Bcl2↑, P21↑, MMP↓, TumCI↓, MMP2↓,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
Dose↝, selectivity↑, TumCCA↑, Apoptosis↑, toxicity↓, ChemoSen↑, other↝, *antiOx↑,
| - |
vitro+vivo, |
Melanoma, |
B16-BL6 |
|
|
|
- |
in-vitro, |
BC, |
E0771 |
|
|
|
- |
in-vitro, |
BC, |
4T1 |
|
|
|
TumCP↓, TumCMig↓, TumCCA↑, CD155↓, Dose↓, other↝, TumCG↓,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
antiOx↑, Inflam↓, AntiCan↓, other↝, BioAv↑, other↝,
| - |
vitro+vivo, |
NPC, |
CNE2 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Lung, |
H1975 |
|
|
|
ATPase↓, HSP90↓, TumCP↓, *toxicity↝, MMP2↓, MMP9↓, HER2/EBBR2↓, c-Raf↓, Akt↓, Bcl-2↓, other↝,
Dose↑, CellMemb↑, eff↝, other↝, TumCG↓,
other↝, AntiTum↑, Dose↝, TumCG↓, ALAT↓, AST↓, hepatoP↑, COX2↓, MMP2↓, MMP9↓,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
CD155↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, ROS↑, 3,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1, c-Raf↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1, AMPK↑, 2, FDG↓, 1, PDH↑, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 4, Bax:Bcl2↑, 1, Bcl-2↓, 1, Casp8↑, 1, Casp9↑, 1, DR4↑, 1, TumCD↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
HER2/EBBR2↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↓, 1, other↝, 15,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP90↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, γH2AX↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
mTOR↓, 1, TumCG↓, 5,
Migration(tgid=13) ⓘ
ATPase↓, 1, MMP2↓, 3, MMP9↓, 2, TumCI↓, 3, TumCMig↓, 3, TumCP↓, 5, TumMeta↓, 1, Vim↓, 1, Vim↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↓, 1, EGR4↓, 1, EPR↑, 1,
Barriers & Transport(tgid=15) ⓘ
CellMemb↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, BioAv↝, 1, ChemoSen↑, 1, Dose↓, 2, Dose↑, 1, Dose↝, 3, eff↓, 1, eff↑, 6, eff↝, 2, Half-Life↓, 1, Half-Life↑, 1, RadioS↑, 1, selectivity↑, 5,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, EGFR↓, 1, Hcy/homoC↓, 1, HER2/EBBR2↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↓, 1, AntiTum↑, 1, chemoP↑, 1, hepatoP↑, 1, toxicity↓, 2,
Total Targets: 65
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, GSH↑, 1, lipid-P↓, 1, ROS↓, 1,
Metal & Cofactor Biology(tgid=2) ⓘ
IronCh↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
GlucoseCon↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
Ach↑, 1, other↓, 1, other↝, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, IL6↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
ChAT↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 2, BioAv↝, 1, Half-Life↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
memory↑, 1, neuroP↑, 1, toxicity↝, 1,
Total Targets: 20
Scientific Paper Hit Count for: other, other
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:767 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page